Canada Pension Plan Investment Board’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292K Buy
34,900
+6,900
+25% +$57.7K ﹤0.01% 1462
2026
Q1
$232K Buy
+28,000
New +$290K ﹤0.01% 1519
2022
Q4
Sell
-31,300
Closed -$657K 1191
2022
Q3
$657K Buy
+31,300
New +$871K ﹤0.01% 945
2021
Q1
Sell
-760
Closed -$68K 1349
2020
Q4
$68K Buy
+760
New +$69.8K ﹤0.01% 1267

Other funds holding EBS

Canada Pension Plan Investment Board's EBS Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Emergent Biosolutions (EBS) stake by 25% in Q2 2026, buying an estimated $57.7K and bringing the position to 34,900 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #1462.

Canada Pension Plan Investment Board first reported a position in EBS in Q4 2020 and has held it in 4 quarters since. The position peaked at $657K in Q3 2022. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Canada Pension Plan Investment Board held 34,900 shares of Emergent Biosolutions worth $292K as of Q2 2026.
  • Canada Pension Plan Investment Board bought 6,900 Emergent Biosolutions shares in Q2 2026, an estimated $57.7K.
  • Emergent Biosolutions made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1462 holding.
  • Canada Pension Plan Investment Board first reported a position in Emergent Biosolutions in Q4 2020 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's Emergent Biosolutions position peaked at $657K in Q3 2022.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.